Intas Pharmaceuticals Ltd.
15Patents
15Active
15Granted
52Portfolio score
Filing activity: Oct 11, 2013 → Oct 17, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9914770B2 | Cloning, expression and purification method for the preparation of ranibizumab | Chemistry; Metallurgy | 4 | Active |
| US11504336B2 | Extended release pharmaceutical composition of clozapine | Human Necessities | 1 | Active |
| US11648207B1 | Extended release pharmaceutical composition of Clozapine | Human Necessities | 1 | Active |
| US11833253B1 | Extended release pharmaceutical composition of Clozapine | Human Necessities | 0 | Active |
| US9487496B2 | Process for the preparation of cabazitaxel and its intermediates | Emerging Cross-Sectional Technologies | 0 | Active |
| US10918698B2 | Lyophilized pharmaceutical composition of Fc-peptide fusion protein | Chemistry; Metallurgy | 0 | Active |
| US11433058B2 | Non-pulsatile prolonged-release betahistine oral solid compositions | Human Necessities | 0 | Active |
| US10688187B2 | Liquid pharmaceutical composition of adalimumab | Chemistry; Metallurgy | 0 | Active |
| US12269830B2 | Process for preparation of tofacitinib and pharmaceutically acceptable salt thereof | Chemistry; Metallurgy | 0 | Active |
| US10052361B2 | Liquid pharmaceutical composition of conjugated erythropoietin | Chemistry; Metallurgy | 0 | Active |
| US9511145B2 | Stable tigecycline composition | Human Necessities | 0 | Active |
| US12280053B2 | Stable, ready to use aqueous pharmaceutical composition of pemetrexed | Human Necessities | 0 | Active |
| US9315540B2 | Process for the preparation of fulvestrant | Chemistry; Metallurgy | 0 | Active |
| US11918590B2 | Stable extended release pharmaceutical composition of clozapine | Human Necessities | 0 | Active |
| US10016447B2 | Pharmaceutical composition having improved content uniformity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.